LOUISVILLE, Ky., Oct. 2, 2024 /PRNewswire/ -- Ambetter from WellCare of Kentucky, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the State Based Exchange will offer residents a variety of affordable health insurance plans in Kentucky in plan year 2025. Open enrollment for the Health Insurance Marketplace for Kentucky runs from Nov. 1, 2024, through Jan. 15, 2025, for coverage starting Jan. 1, 2025. Enroll by Dec. 15, 2024, for coverage starting Jan. 1, 2025.
"Whether it's people that don't have health insurance from their employer or it's people that no longer qualify for Medicaid, each year more individuals and families are choosing Ambetter from WellCare of Kentucky. With Ambetter, they know they'll have access to a wide range of affordable healthcare services," said Plan President and Chief Executive Officer of WellCare of Kentucky Corey Ewing. "We offer comprehensive healthcare coverage with essential health benefits that Kentuckians need to be healthy."
Ambetter from WellCare of Kentucky offers its members access to quality care, convenient services and valuable rewards. 2025 benefits and offerings include:
Below is the full list of counties in which Ambetter from WellCare of Kentucky will be offered:
Kentucky residents interested in learning more about Ambetter from WellCare of Kentucky or enrolling in a health plan during the open enrollment period may visit Ambetter.wellcareky.com.
About Ambetter from WellCare of Kentucky
Ambetter from WellCare of Kentucky serves under-insured and uninsured populations through the Kentucky State Based Exchange, Kynect. Ambetter from WellCare of Kentucky is underwritten by WellCare Health Plans of Kentucky, Inc., which is a Qualified Health Plan issuer in Kentucky. For more information, visit ambetterhealth.com/en/ky/. This is a solicitation for insurance. For information on your right to receive from an Ambetter from WellCare of Kentucky plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$53.76 |
Daily Change: | -0.23 -0.43 |
Daily Volume: | 2,504,374 |
Market Cap: | US$27.140B |
April 25, 2025 February 24, 2025 February 04, 2025 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load